SCHEMBL23280197

SCHEMBL23280197

CNCCCOC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ UBASH3B Q8TF42 1/20 0.69
▸ TACR1 P25103 7/20 0.51
▸ CCKBR P32239 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ F11 P03951 2/20 0.45
▸ KMT2A Q03164 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ PPARG P37231 1/20 0.42
▸ LNPEP Q9UIQ6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16666780 0.95 UBASH3B (0.71) UBASH3BTACR1CCKBRKDM4EALDH1A1
SCHEMBL16666781 0.90 UBASH3B (0.69) UBASH3BTACR1CCKBRKDM4EALDH1A1
SCHEMBL16666451 0.89 UBASH3B (0.74) UBASH3BTACR1CCKBRKDM4EALDH1A1
SCHEMBL16666493 0.89 UBASH3B (0.68) UBASH3BTACR1CCKBRKDM4EALDH1A1
SCHEMBL16666561 0.88 UBASH3B (0.72) UBASH3BTACR1CCKBRKDM4EALDH1A1
SCHEMBL16666431 0.88 UBASH3B (0.75) UBASH3BTACR1CCKBRKDM4EALDH1A1
SCHEMBL16666556 0.88 UBASH3B (0.71) UBASH3BTACR1CCKBRKDM4EALDH1A1
SCHEMBL16666247 0.87 UBASH3B (0.74) UBASH3BTACR1CCKBRKDM4EALDH1A1
SCHEMBL16666555 0.87 UBASH3B (0.76) UBASH3BTACR1CCKBRKDM4EALDH1A1
SCHEMBL16666855 0.87 UBASH3B (0.79) UBASH3BTACR1CCKBRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2865669-B1 NOVEL REBAMIPIDE PRODRUG, METHOD FOR PRODUCING SAME, AND USAGE THEREOF SAMJIN PHARM CO LTD (KR) 2021-04-28 — — EP disclosed
Send feedback